Alvotech Q1 2024 GAAP EPS $(0.89) Up From $(1.24) YoY
ALVOMay 21, 2024
Read more →Stocks Hold Steady On Mixed Fed Remarks, First Solar Rallies, Bitcoin Falls Below $70,000: What's Driving Markets Tuesday?
ALVOIt’s a rather quiet session on Tuesday, with major U.S. averages trading around the flatline at midday trading in New York.
May 21, 2024
Read more →Alvotech And Dr. Reddy's Enter Collaboratoin For Commercialization Of Prolia & Xgeva Biosimilar, AVT03
ALVOMay 21, 2024
Read more →Reported Earlier, Teva And Alvotech Announce U.S. Launch Of Simlandi (adalimumab-ryvk), The First Interchangeable High-Concentration, Citrate-Free Biosimilar To Humira
ALVOMay 21, 2024
Read more →